{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:02:45Z","timestamp":1755036165182},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,14]]},"DOI":"10.7759\/cureus.38995","type":"journal-article","created":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T12:32:16Z","timestamp":1684067536000},"source":"Crossref","is-referenced-by-count":1,"title":["Heterogeneous Comorbidity in Individuals With Different Phenotypes of Obesity"],"prefix":"10.7759","author":[{"given":"Albina R","family":"Nurieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil D","family":"Parve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina V","family":"Sineglazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Obesity and overweight. (2021). Accessed. January 20, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396:1223-49. 10.1016\/S0140-6736(20)30752-2","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029617","article-title":"Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management","volume":"137","author":"Neeland IJ","year":"2018","unstructured":"Neeland IJ, Poirier P, Despr\u00e9s JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018, 137:1391-406. 10.1161\/CIRCULATIONAHA.117.029617","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.02.031","article-title":"21st century advances in multimodality imaging of obesity for care of the cardiovascular patient","volume":"14","author":"Neeland IJ","year":"2021","unstructured":"Neeland IJ, Yokoo T, Leinhard OD, Lavie CJ. 21st century advances in multimodality imaging of obesity for care of the cardiovascular patient. JACC Cardiovasc Imaging. 2021, 14:482-94. 10.1016\/j.jcmg.2020.02.031","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.20969\/VSKM.2021.14(1).41-46","article-title":"The profile of risk factors for chronic non-communicable diseases among distinct phenotypes of obesity [Russian]","volume":"14","author":"Nurieva AR","year":"2021","unstructured":"Nurieva AR, Sineglazova AV, Kim TY, Parve S. The profile of risk factors for chronic non-communicable diseases among distinct phenotypes of obesity [Russian]. Bull Contemp Clin Med. 2021, 14:41-46. 10.20969\/VSKM.2021.14(1).41-46","journal-title":"Bull Contemp Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30074-9","article-title":"Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120\u2008813 adults from 16 cohort studies from the USA and Europe","volume":"2","author":"Kivim\u00e4ki M","year":"2017","unstructured":"Kivim\u00e4ki M, Kuosma E, Ferrie JE, et al.. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120\u2008813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017, 2:e277-85. 10.1016\/S2468-2667(17)30074-9","journal-title":"Lancet Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.969753","article-title":"Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: a population-based prospective study","volume":"13","author":"Wang Y","year":"2022","unstructured":"Wang Y, Zhao X, Chen Y, et al.. Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: a population-based prospective study. Front Endocrinol (Lausanne). 2022, 13:969753. 10.3389\/fendo.2022.969753","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2018.06.004","article-title":"Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update","volume":"61","author":"Pich\u00e9 ME","year":"2018","unstructured":"Pich\u00e9 ME, Poirier P, Lemieux I, Despr\u00e9s JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis. 2018, 61:103-13. 10.1016\/j.pcad.2018.06.004","journal-title":"Prog Cardiovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00033-X","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","volume":"10","author":"Kivim\u00e4ki M","year":"2022","unstructured":"Kivim\u00e4ki M, Strandberg T, Pentti J, et al.. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022, 10:253-63. 10.1016\/S2213-8587(22)00033-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.10.024","article-title":"Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis","volume":"10","author":"Shah RV","year":"2017","unstructured":"Shah RV, Anderson A, Ding J, et al.. Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging. 2017, 10:1016-27. 10.1016\/j.jcmg.2016.10.024","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279\u2009013 individuals","volume":"39","author":"Lauridsen BK","year":"2018","unstructured":"Lauridsen BK, Stender S, Kristensen TS, Kofoed KF, K\u00f8ber L, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279\u2009013 individuals. Eur Heart J. 2018, 39:385-93. 10.1093\/eurheartj\/ehx662","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim S","year":"2019","unstructured":"Lim S, Taskinen MR, Bor\u00e9n J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obes Rev. 2019, 20:599-611. 10.1111\/obr.12820","journal-title":"Obes Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1114963","article-title":"The relationship between fat distribution in central region and comorbidities in obese people: based on NHANES 2011-2018","volume":"14","author":"Liu CA","year":"2023","unstructured":"Liu CA, Liu T, Ruan GT, et al.. The relationship between fat distribution in central region and comorbidities in obese people: based on NHANES 2011-2018. Front Endocrinol (Lausanne). 2023, 14:1114963. 10.3389\/fendo.2023.1114963","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09796-3","article-title":"Relevance of body composition in phenotyping the obesities","author":"Salm\u00f3n-G\u00f3mez L","year":"2023","unstructured":"Salm\u00f3n-G\u00f3mez L, Catal\u00e1n V, Fr\u00fchbeck G, G\u00f3mez-Ambrosi J. Relevance of body composition in phenotyping the obesities. Rev Endocr Metab Disord. 2023, 10.1007\/s11154-023-09796-3","journal-title":"Rev Endocr Metab Disord"},{"key":"ref15","unstructured":"Body mass index - BMI. (2010). Accessed. January 20, 2023: http:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren FL","year":"2021","unstructured":"Visseren FL, Mach F, Smulders YM, et al.. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021, 42:3227-337. 10.1093\/eurheartj\/ehab484","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino F","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, et al.. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020, 41:255-323. 10.1093\/eurheartj\/ehz486","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04142.x","article-title":"Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care","volume":"30","author":"Jones R","year":"2009","unstructured":"Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, Lind T. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009, 30:1030-8. 10.1111\/j.1365-2036.2009.04142.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref21","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016, 64:1388-1402.","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.10.004","article-title":"Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis","volume":"36","author":"Chiu HY","year":"2017","unstructured":"Chiu HY, Chen PY, Chuang LP, et al.. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev. 2017, 36:57-70. 10.1016\/j.smrv.2016.10.004","journal-title":"Sleep Med Rev"},{"key":"ref23","article-title":"The Global Prevalence of Anaemia in 2011","author":"WHO","year":"2015","unstructured":"WHO. The Global Prevalence of Anaemia in 2011. World Health Organization, Geneva; 2015."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.med.0000433067.01671.f5","article-title":"A complications-based clinical staging of obesity to guide treatment modality and intensity","volume":"20","author":"Daniel S","year":"2013","unstructured":"Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013, 20:377-88. 10.1097\/01.med.0000433067.01671.f5","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)00082-6","article-title":"Phenotypes of prediabetes and stratification of cardiometabolic risk","volume":"4","author":"Stefan N","year":"2016","unstructured":"Stefan N, Fritsche A, Schick F, H\u00e4ring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol. 2016, 4:789-798. 10.1016\/S2213-8587(16)00082-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.17513\/spno.31669","article-title":"Association of impaired fasting glycemia with other cardiometabolic risk factors [Russian]","volume":"2","author":"Nurieva AR","year":"2022","unstructured":"Nurieva AR, Kim TY, Parve SD, Asatullina ZR, Sineglazova AV. Association of impaired fasting glycemia with other cardiometabolic risk factors [Russian]. Modern Probl Sci Educ. 2022, 2:134. 10.17513\/spno.31669","journal-title":"Modern Probl Sci Educ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152613-heterogeneous-comorbidity-in-individuals-with-different-phenotypes-of-obesity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:39Z","timestamp":1707508779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152613-heterogeneous-comorbidity-in-individuals-with-different-phenotypes-of-obesity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,14]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.38995","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,14]]}}}